Atrial Fibrillation (AF)FINDER-AFNCT06892938
Detection and Classification of Cardiac Rhythm and Atrial Fibrillation Using a Finger-worn Ring
An observational study of Atrial Fibrillation (AF) and Arrhythmias Cardiac, run by Everbeat at 3 sites in United States.
Trial summary
Everbeat is a finger-worn ring that has a built-in electrocardiogram (ECG). In this study the investigators ensure that the ECG as read by the everbeat correctly classifies heart rhythms and detects atrial fibrillation. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Atrial Fibrillation (AF), Arrhythmias Cardiac, Tachycardia
- What is being tested?
- Atrial Fibrillation Identification
- How many people
- 232 participants
- Where
- 3 sitesUnited States
- Study dates
- 17 Sep 2024to 1 Apr 2025
- How long will I take part?
- 1 Day
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Patients with or without cardiac arrhythmic history who are 18 years or older and do not have an implanted cardiac device.
Who may be able to join
- 18 years of age or older
Who cannot join
- Presence of pacemaker or defibrillator
- Inability to wear a ring in size range available
Trial locations and contacts
3 sites in 1 country.
United States3 sites
Our Lady of Lake Hospital
Baton Rouge, Louisiana, 70808
XIMED
La Jolla, California, 92037
Allegheny General Hospital
Pittsburgh, Pennsylvania, 15232
About this study
Official title: Finger Worn Detection Via Electrocardiographic Ring of Atrial Fibrillation and ECG Waveform Analysis (FINDER-AF)
Everbeat is a finger-worn ring that has a built-in electrocardiogram (ECG). In this study the investigators ensure that the ECG as read by the everbeat correctly classifies heart rhythms and detects atrial fibrillation. Investigators will also correlate the everbeat ECG waveform with a clinical-grade FDA approved electrocardiogram to ensure it may be reliably interpreted by clinicians or other algorithms.
Read the detailed description
In this study the participant will obtain a simultaneous electrocardiogram from both the everbeat ring system and a clinical-grade diagnostic ECG machine for correlation and analysis.
- Being tested
- Atrial Fibrillation Identification
- Keywords
- Atrial Fibrillation, Wearable Monitor, Electrocardiogram, Ring
- Medical subject headings
- Atrial Fibrillation, Arrhythmias, Cardiac, Tachycardia, Bradycardia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Atrial Fibrillation IdentificationDiagnostic test
Identification of atrial fibrillation by device.
| Study group | Role | What they receive |
|---|---|---|
| Atrial Fibrillation history | Atrial fibrillation history or active atrial fibrillation Receives: Diagnostic Test: Atrial Fibrillation Identification | |
| Normal heart rhythm | Patients with no history of prior or active heart arrhythmia Receives: Diagnostic Test: Atrial Fibrillation Identification |
What is being measured
The primary outcome is the main question the study is designed to answer.
Rhythm classification
Automated rhythm characterization by the ring device as normal sinus rhythm, atrial fibrillation or other.
Measured: Baseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 Mar 2025
- Study start17 Sep 2024
- Primary completion12 Mar 2025
- Study completion1 Apr 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Atrial Fibrillation (AF)Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Enrolment
- 232 participants (actual)
- Target duration
- 1 Day
Sponsor and investigators
- Lead sponsor
- Everbeat
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
- Investigators
- Kenneth Civello, MD, Principal investigator, Our Lady of Lake Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06892938
- Sponsor's protocol ID
- EVB002
- Acronym
- FINDER-AF
- Status last verified
- Mar 2025
- First submitted
- 18 Mar 2025
- Last updated
- 27 Mar 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- Yes
- Individual data sharing
- No: Single study
Study at a glance
From the registry record, last updated by the sponsor on 27 Mar 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Finger Worn Detection Via Electrocardiographic Ring of Atrial Fibrillation and ECG Waveform Analysis (FINDER-AF)
- ClinicalTrials.gov ID
- NCT06892938
- Acronym / sponsor ID
- FINDER-AF / EVB002
- Keywords
- Atrial Fibrillation, Wearable Monitor, Electrocardiogram, Ring
- Study type
- Observational
- Recruitment status
- Active, not recruiting
- Enrolment
- 232 participants (actual)
- Lead sponsor
- EverbeatIndustry (pharma, biotech, devices)
- Study start
- 17 Sep 2024 (actual)
- Primary completion
- 12 Mar 2025 (actual)
- Study completion
- 1 Apr 2025 (estimated)
- First posted
- 25 Mar 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Everbeat is a finger-worn ring that has a built-in electrocardiogram (ECG). In this study the investigators ensure that the ECG as read by the everbeat correctly classifies heart rhythms and detects atrial fibrillation. Investigators will also correlate the everbeat ECG waveform with a clinical-grade FDA approved electrocardiogram to ensure it may be reliably interpreted by clinicians or other algorithms.
Detailed description
In this study the participant will obtain a simultaneous electrocardiogram from both the everbeat ring system and a clinical-grade diagnostic ECG machine for correlation and analysis.
Study design
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Target follow-up
- 1 Day
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Atrial Fibrillation history | – | Diagnostic Test: Atrial Fibrillation IdentificationAtrial fibrillation history or active atrial fibrillation |
| Normal heart rhythm | – | Diagnostic Test: Atrial Fibrillation IdentificationPatients with no history of prior or active heart arrhythmia |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Patients with or without cardiac arrhythmic history who are 18 years or older and do not have an implanted cardiac device.
Key inclusion criteria (1 listed)
- 18 years of age or older
Key exclusion criteria (2 listed)
- Presence of pacemaker or defibrillator
- Inability to wear a ring in size range available
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Atrial Fibrillation IdentificationIdentification of atrial fibrillation by device. | Diagnostic test | Atrial Fibrillation history, Normal heart rhythm |
Primary outcome
Rhythm classification
Time frame: Baseline
Automated rhythm characterization by the ring device as normal sinus rhythm, atrial fibrillation or other.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Mar 2025.
- Individual participant dataSharing planned: No. Single study
Related trials for Atrial Fibrillation (AF)
Active, not recruiting
Horizon 360 Protocol for the Treatment of Paroxysmal Atrial Fibrillation With the Sphere-360™ Catheter and Affera™ Mapping and Ablation System (Horizon 360)
Paroxysmal AF
Active, not recruiting
CONVERGE Post-Approval Study (PAS)
Chronic Atrial Fibrillation
RecruitingPhase 2
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
Atrial Fibrillation (AF)
RecruitingPhase 3
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
Atrial Fibrillation (AF)
Not yet recruitingObservational study
Hummingbird ICE Study
ATRIAL APPENDAGE CLOSURE for ATRIAL FIBRILLATION, Atrial Fibrillation (AF)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Kenneth Civello, MD principal investigator
Our Lady of Lake Hospital
3 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Atrial Fibrillation (AF) and Arrhythmias Cardiac, run by Everbeat at 3 sites in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 27 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 3 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Rhythm classification (time frame: Baseline). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Mar 2025.